Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01396811 · ClinicalTrials.gov registry record · Phase 3
Topical Antifungal Treatment for Tinea Pedis
A Phase 3 study, sponsored by Medicis Global Service Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 322
- Enrollment target
NCT01396811: Completed Phase 3 study, sponsored by Medicis Global Service Corporation.
NCT01396811 is a Phase 3 study that has completed, run by Medicis Global Service Corporation. The registered enrollment target is 322 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (58% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01396811, a Phase 3 study, has completed, sponsored by Medicis Global Service Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 322 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a topical antifungal cream is safe and effective for the treatment of tinea pedis.
Primary Outcome
Signs and Symptoms Severity Score and negative Potassium Hydroxide (KOH) and Culture
Interventions
- DRUG Placebo
- DRUG 33525
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 322 participants |
| Start Date | 2011-07 |
| Est. Completion | 2012-03 |
| Phase | Phase 3 |
What the finished NCT01396811 record still lists
NCT01396811 is an interventional study that assigns participants to a tested intervention. The registered 322 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (58% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01396811 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01396811 about?
NCT01396811 is a clinical study titled "Topical Antifungal Treatment for Tinea Pedis". The purpose of this study is to determine if a topical antifungal cream is safe and effective for the treatment of tinea pedis.
What is the current status of trial NCT01396811?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 322 participants. The study started on 2011-07. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01396811?
The interventions under investigation include: Placebo (DRUG), 33525 (DRUG).
Who is sponsoring clinical trial NCT01396811?
This trial is sponsored by Medicis Global Service Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01396811's enrollment target sits among peer trials
322 1081st of 2000 higher than 920 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04090359 · 322 participants · Phase 4
Dual Mobility Acetabular Cups in Revision TJA
- NCT04924075 · 322 participants · Phase 2
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- NCT03715933 · 321 participants · Phase 1
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- NCT05922878 · 321 participants · Phase 2
Study of ALTO-300 in MDD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia